Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Robert van Dam
University of California Los Angeles, Department: Biochemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
Sofie Biosciences
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
PI is the head of the study. PI has stock in the company.
Novel microscale purification methods for complete microfluidic production of high molar activity PET radiotracers
RELEVANCE TO PUBLIC HEALTH Due to compact size and small reagent volumes, microscale methods promise to enable high molar activity radiotracers for positron emission tomography (PET) imaging to be produced at lower cost than conventional methods. The proposed research will develop the last critical missing piece of microscale radiochemistry technology, namely a microscale purification system. By enabling routine, low-cost access to diverse tracers, the combination of microscale synthesis and purification technologies will facilitate and accelerate the development and clinical translation of emerging and novel PET tracers.
Filed on March 20, 2019.
Tell us what you know about Robert van Dam's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Robert van Dam filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Robert van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC | $350,000 - $399,999 |
| Robert Michael van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC. | $200,000 - $249,999 |
| Robert Michael van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC. | $40,000 - $59,999 |
| Robert van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC | $5,000 - $9,999 |
| Robert Michael van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC. | Value cannot be readily determined |
| Robert van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.